Rights and permissions
About this article
Cite this article
Economic burden of migraine “very significant” in Brazil. Pharmacoecon. Outcomes News 425, 7 (2003). https://doi.org/10.1007/BF03276645
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276645